KCT0004979招募中未知
Determination of optimal cutoff value of tongue body color among chronic fatigue patients: A cross-sectional study
Sangji University Oriental Medical Center0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1) Adults over 19 years
- •2) Those who satisfy the following three conditions of 'Modified 1994 research case definition criteria for chronic fatigue syndrome worksheet'
- •? Clinically evaluated, unexplained, persistent or relapsing chronic fatigue that is of new or definite onset
- •? The concurrent occurrence of four or more of the following symptoms, all of which must have persisted or recurred during 6 or more consecutive months of illness and must not have predated the fatigue
- •? Exclusion of other clinical causes that may explain fatigue in health screening after the onset
排除标准
- •(1) Those who can not open their mouths due to jaw joint disorders
- •(2) Glossities, Anatomical abnormality on the tongue, or intraoral bleeding disorders
- •(3) Orthodontic prostheses in the mouth
- •(4) Smokers
- •(5) Sleep apnea or narcolepsy
- •(6) New drugs within one month
- •(7) currently taking drugs cause fatigue or drowsiness
- •(8) History of malignant tumors, chronic hepatitis, or liver cirrhosis
- •(9) History of major depressive disorder, bipolar affective disorders, schizophrenia, dementia, anorexia nervosa, bulimia
- •(10) History of chronic renal failure, tuberculosis, asthma, or multiple sclerosis
- •(11) History of alcohol or other substance abuse from 2 years before the onset of fatigue into the time of screening
- •(12) Myocardial infarction, Unstable angina pectoris, Stroke, Cerebral ischemic attack, heart failure, uncontrolled arrhythmia, and previous coronary revascularization
- •(13) Severe metabolic disease / Cardiovascular, cerebrovascular disease / Any other diseases or disorders that may affect physical and mental fatigue/ systemic infectious disease requiring treatment
- •(14) Uncontrolled hypertension (SBP >180mmHg or DBP >110 mmHg) or edema
- •(15) BMI greater that 45 kg/m2
- •(16) Positive HBsAg, HCB-Ab, HIV test
- •(17) Serum creatinine >UNL X 2 times
- •(18) HbA1c > 9%
- •(19) AST, ALT, or serum bilirubin >UNL X 2.5 times
- •(20) TSH below 0.40 mIU/L or over 4.0 mIU/L
- •(21) Currently receiving treatment to improve fatigue
- •(22) Pregnant, lactating, or fertile women, or positive urine pregnancy test results
- •(23) Participants in any other clinical studies within one month of screening
- •(24) Anyone who is deemed unsuitable for other clinically significant medical or psychiatric findings
研究者
相似试验
尚未招募
4 期
Assessing pain relief after the operation after administering the pain killer injection during operation according to measurement done (SPI) using special monitor.CTRI/2018/02/012150SDM College of Medical Sciences and Hospital
已完成
不适用
TopQ Cut-Off Determination StudyHealthyNCT01824784Topcon Medical Systems, Inc.10
尚未招募
不适用
To determine the amount of air needed to fill the cuff of the endotracheal tubeCTRI/2022/12/048596Preetham V
已完成
不适用
Evaluation of the Jaw Index for the determination of micrognathia and visualization of the facial profile using 3D photography in healthy newborns and infants with Pierre Robin sequence and their first-degree relativesMedDRA - 10035009Q87.0Congenital malformation syndromes predominantly affecting facial appearanceDRKS00017769niversitätsklinikum Tübingen58
未知
不适用
DEFINING THE CRITERIA FOR ESTABLISHING THE OPTIMAL SUPPLEMENTATION SCHEMA WITH POWDERED MICRONUTRIENTS FOR ANEMIA CONTROL AND MICRONUTRIENTS DEFICIENCIES IN CHILDREPER-029-11Micronutrient Initiative,